the aid library

LIST OPTIONS

Filter

13360

Review of the National Tuberculosis Programme: Myanmar, 7-15 November 2011

World Health Organization (WHO) (2012) C_WHO

Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)... more

Download (850)

View PDF (1312)

WHO Profile on mental health in development (WHO proMIND): Sierra Leone

World Health Organization (WHO), Department of Mental Health and Substance Abuse (2012) C_WHO

Download (255)

View PDF (396)

Action plan for the health sector response to HIV in the WHO European Region

World Health Organization WHO, Regional Office for Europe (2017) C_WHO

Download (2128)

View PDF (6552)

Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola
recommended

World Health Organization (2014)

This document provides a summary of infection control recommendations when providing direct and non-direct care to patients with suspected or confirmed Filovirus haemorrhagic fever (HF), including Ebola or Marburg haemorrhagic fevers. These recommendations are interim and will be updated when additi... more

External Link

Potential Risk of Dengue and Chikungunya Outbreaks in Northern Italy Based on a Population Model of Aedes albopictus (Diptera: Culicidae)

Giorgio Guzzetta, Fabrizio Montarsi, Frédéric Alexandre Baldacchino et al. (2016) CC

PLoS Neglected Tropical Diseases https://doi.org/10.1371/journal.pntd.0004762 This study shows the importance of an integrated entomological and medical surveillance for the evaluation of arboviral disease risk, which is a precondition for designing cost-effective vector control programs.

External Link

WHO Country Cooperation Strategy 2008-2013 Sierra Leone

World Health Organization (2008) C_WHO

Download (277)

View PDF (452)

Haiti: What did we learn? The Shelter Response and Housing Recovery in the First Two Years after the 2010 Haiti Earthquake

GFDRR Habitat for Humanity IFRC; et al. (2016) CC

This report is not a formal evaluation, but rather a synthesis of the experiences, observations, and recommendations of a large group of experienced post-disaster shelter and recovery experts gathered from interviews, surveys, and direct discussions, and information derived from a desk review of the... more

Download (703)

View PDF (876)

National Strategic Plan for Early Childhood Intervention [2017-2021]

The Republic of the Union of Myanmar (2017) C1

A National Service Programme for All Children with Special Needs and their Families
In Myanmar, we estimate that at least 40% of children require ECI services for short to longer periods of time. At present, 35.1% of Myanmar children are moderately to severely stunted; all of these children are l... more

Download (669)

View PDF (898)

Guidelines for the diagnosis and treatment of Chagas disease
recommended

World Health Organization WHO (2019) C_WHO

This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev... more

Download (362)

View PDF (776)

Tuberculosis - Regional plan for Tuberculosis control, 2006 – 2015

World Health Organization; Pan American Health Organization (2005) C_WHO

External Link

EU Action on Antimicrobial Resistance

Euroepan Union (2022) CC

Antimicrobial resistance (AMR) – the ability of microorganisms to resist antimicrobial treatments, especially antibiotics – has a direct impact on human and animal health and carries a heavy economic burden due to higher costs of treatments and reduced productivity caused by sickness. AMR is res... more

Download (873)

View PDF (1333)

Management of Type 2 Diabetes. Training Manual

WHO Collaborating Centre for Capacity Building and Research in Community-based Noncommunicable Disease Prevention and Control, All India Institute of Medical Sciences (AIIMS), New Delhi, India. World Health Organization WHO, India (2019) C_WHO

WHO Package of Essential NCD Interventions (PEN) Accessed March 18,2019

Download (532)

View PDF (636)

Step by Step Guide: Humanitarian Programme Cycle 2022

Office for the Coordination of Humanitarian Affairs OCHA (2021) CC

The steps reassert the sequence of the HPC, with needs analysis directly informing decisions about the response and monitoring, whether for the preparation of new plans or adjustments to existing ones. The steps of the HPC have a rationale and cannot be skipped. However, the depth of work under each... more

Download (536)

View PDF (679)

National Human Resources Policy and Plan for Health and Social Welfare 2011-2021

Republic of Liberia, Ministry of Health and Social Welfare (2017) C1

Download (324)

View PDF (323)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more